ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
about
Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathwayGREB1 functions as a growth promoter and is modulated by IL6/STAT3 in breast cancerDifferences between invasive lobular and invasive ductal carcinoma of the breast: results and therapeutic implicationsCytoplasmic PELP1 and ERRgamma protect human mammary epithelial cells from Tam-induced cell deathProgesterone receptor-B enhances estrogen responsiveness of breast cancer cells via scaffolding PELP1- and estrogen receptor-containing transcription complexesAffinity of estrogens for human progesterone receptor A and B monomers and risk of breast cancer: a comparative molecular modeling studyERRβ signalling through FST and BCAS2 inhibits cellular proliferation in breast cancer cells.Identification and characterization of estrogen receptor-related receptor alpha and gamma in human glioma and astrocytoma cells.ERK/MAPK regulates ERRγ expression, transcriptional activity and receptor-mediated tamoxifen resistance in ER+ breast cancer.Multilevel support vector regression analysis to identify condition-specific regulatory networksPartial inhibition of estrogen-induced mammary carcinogenesis in rats by tamoxifen: balance between oxidant stress and estrogen responsivenessInvasive lobular carcinoma of the breast: morphology, biomarkers and 'omicsLobular breast cancer: molecular basis, mouse and cellular models.MicroRNA-320a sensitizes tamoxifen-resistant breast cancer cells to tamoxifen by targeting ARPP-19 and ERRγCombinational treatment of gap junctional activator and tamoxifen in breast cancer cells.ERRγ target genes are poor prognostic factors in Tamoxifen-treated breast cancer.The pERK of being a target: Kinase regulation of the orphan nuclear receptor ERRγ.Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial.A long AAAG repeat allele in the 5' UTR of the ERR-γ gene is correlated with breast cancer predisposition and drives promoter activity in MCF-7 breast cancer cells.ERRβ splice variants differentially regulate cell cycle progression.Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer.Orphan nuclear receptors in breast cancer pathogenesis and therapeutic response.Genome-wide mapping of FOXM1 binding reveals co-binding with estrogen receptor alpha in breast cancer cells.Estrogen-related receptor γ is upregulated in liver cancer and its inhibition suppresses liver cancer cell proliferation via induction of p21 and p27Transcriptional cross talk between orphan nuclear receptor ERRγ and transmembrane transcription factor ATF6α coordinates endoplasmic reticulum stress response.WNT4 mediates estrogen receptor signaling and endocrine resistance in invasive lobular carcinoma cell lines.Expression of a phosphorylated p130(Cas) substrate domain attenuates the phosphatidylinositol 3-kinase/Akt survival pathway in tamoxifen resistant breast cancer cells.Antimitotic activity of DY131 and the estrogen-related receptor beta 2 (ERRβ2) splice variant in breast cancer.Invasive lobular carcinoma cell lines are characterized by unique estrogen-mediated gene expression patterns and altered tamoxifen responseHsa-miR-375 is differentially expressed during breast lobular neoplasia and promotes loss of mammary acinar polarity.Establishment of primary mixed cell cultures from spontaneous canine mammary tumors: Characterization of classic and new cancer-associated molecules.Polymorphic AAAG repeat length in estrogen-related receptor gamma (ERRγ) and risk of breast cancer in Iranian women.Integrated molecular analysis of Tamoxifen-resistant invasive lobular breast cancer cells identifies MAPK and GRM/mGluR signaling as therapeutic vulnerabilities.Gene expression profile and cancer-associated pathways linked to progesterone receptor isoform a (PRA) predominance in transgenic mouse mammary glands.Key regulators of lipid metabolism drive endocrine resistance in invasive lobular breast cancerEndocrine Resistance in Breast Cancer
P2860
Q21135589-2E9F2F3E-A896-4DB9-B510-9BA6DFB6711FQ21560759-F92A42D4-DE9A-4260-B215-4DEA5DF81AD2Q26740072-B2ABCDF3-3426-4BAC-9F81-0C67AB1F3BF2Q28259195-AD795E16-F9A1-4EEE-8985-70F8F8505BAAQ28306753-80DCF601-EF6F-4B4B-95DB-F69706496405Q28740541-0FFEA7CC-3C72-4258-944F-5869951C191AQ30576405-DF372739-D86D-412B-BC1D-EADD10E2D3E0Q33624835-3F190147-83AF-4717-B9CA-14B32EB31D25Q33836140-64FA3294-36F4-4B12-9F60-A89B9B5A30CFQ33857304-2C2DA33A-060C-4D52-BCE3-D41D9E1D3ACFQ34038020-2DBF292C-BAEC-4425-BDB8-DA7761C7D859Q35025646-EEE0E331-3717-410C-A819-9A163BA4DA20Q35059856-8479C117-6D0C-4072-A6BB-30CAA4E2D561Q35144274-25FC8586-93A8-416B-A688-263DF97C9F8FQ35230023-663EAB0F-96E9-4CAC-B40F-E47E5FA8AE4BQ35620279-74F2CC8A-DA03-43F8-A74D-FC5D49716853Q35634158-C8E6F8C3-62E8-4235-807F-23249F21D00DQ35998828-BD833917-4DC9-4139-982B-3750685FB742Q36030812-33D68187-68DC-468D-870E-36132CB92799Q36187539-333F0D58-10F8-47B2-A8F1-F1F64B9C20D1Q36214982-1E244E6F-C399-4AD0-ACE0-8C89BAB6A063Q36455407-03767A6D-2B57-42A4-B786-E8F8BCA095FEQ36872440-C1AF9745-FF4E-4644-9AFB-13B1A68A5F69Q36968020-68860E18-5288-4C71-A9BC-BF869557F58BQ37080357-BC725D55-32DF-4702-A5BC-4FFEBD193DD7Q37267630-8B0BFD46-5781-4561-8EDC-D16F1396143DQ37345203-E0B682D4-30F6-444A-9813-88151857B569Q37565093-FBDCA4AE-CD34-4C76-8B8B-E95A9B44DD60Q37639160-C62E88B9-34FE-4100-8F0E-0FAD84E09A6DQ38407966-938FC7C3-7890-4525-84D4-14F4385C85C3Q42363522-58091907-3849-4527-8959-720AD207539FQ44755975-1644EA57-2654-4A85-951D-192A5B09F2F5Q46311036-30D03768-A524-4320-A9CA-F18257210B1AQ55497683-EFD84E34-4BF0-406C-90BD-4AAFEF596121Q58765163-901BC32F-1E6E-49D4-A5DE-5424FB9276B9Q59072640-C017E708-FB8B-4B19-8D55-01D5A5C4CDD9
P2860
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
@en
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
@nl
type
label
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
@en
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
@nl
prefLabel
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
@en
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
@nl
P2093
P2860
P1433
P1476
ERRgamma mediates tamoxifen resistance in novel models of invasive lobular breast cancer.
@en
P2093
Alan Zwart
Bassem R Haddad
Jennifer P-J Lan
Jianhua Xuan
Luciane R Cavalli
Rebecca B Riggins
Robert Clarke
Stephen P Ethier
P2860
P304
P356
10.1158/0008-5472.CAN-08-2669
P407
P577
2008-11-01T00:00:00Z